Bilateral renal cell carcinoma (RCC) is an extremely rare renal tumor, which even more infrequently presents with two different types of pathology. We present a case of bilateral RCC in a 56-year-old male patient treated with simultaneous retroperitoneal laparoscopic nephron-sparing surgery (RLNSS). The postoperative histopathologic examination identified the left tumor as a clear cell carcinom...

objective(s): the ability to measure cellular proliferation non-invasively in renal cell carcinoma may allow prediction of tumour aggressiveness and response to therapy. the aim of this study was to evaluate the uptake of 18ffluorothymidine (flt) pet in renal cell carcinoma (rcc), and to compare this to 18f-fluorodeoxyglucose (fdg), and to an immunohistochemical measure of cellular proliferatio...

Chromophobe renal cell carcinoma (ChRCC) is a variant of RCC with certain histological, immunohistological and cytogenetic characteristics. It is believed to arise from the intercalated cells of distal tubules and has a more favourable prognosis than other more common subtypes, clear cell and papillary RCC. Microscopically, neoplastic cells of ChRCC are typically arranged in solid sheets, trabe...

BACKGROUND Renal cell carcinoma (RCC) is the tenth most commonly diagnosed cancer in the United States. While it is usually lethal when metastatic, RCC is successfully treated with surgery when tumors are confined to the kidney and have low tumor volume. Because most early stage renal tumors do not result in symptoms, there is a strong need for biomarkers that can be used to detect the presence...

background and objectives: rcc is one of the most common genitourinary cancers. accurate prediction of prognosis would be valuable for adjuvant trial design, counseling and effectively scheduling follow up visits. p53 is a tumor suppressor gene that expresses a protein that involved in both cell-cycle arrests after dna damage and apoptosis. presence of mutated p53 protein in tumors has been rel...